REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

Accredited Investors Inc.'s Holding History (CIK: 0001518364)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 12,845 Value ($000) $67 Avg Close — Range —
Q1 2024
Shares 12,845 Value ($000) $63 Avg Close — Range —
Q4 2023
Shares 12,845 Value ($000) $113 Avg Close — Range —
Q3 2023
Shares 12,845 Value ($000) $147 Avg Close — Range —
Q2 2023
Shares 12,845 Value ($000) $325 Avg Close — Range —
Q1 2023
Shares 20,491 Value ($000) $660 Avg Close — Range —
Q4 2022
Shares 20,491 Value ($000) $378 Avg Close — Range —
Q3 2022
Shares 20,491 Value ($000) $553 Avg Close — Range —
Q2 2022
Shares 20,491 Value ($000) $283 Avg Close — Range —
Q1 2022
Shares 20,491 Value ($000) $400 Avg Close — Range —
Q4 2021
Shares 20,491 Value ($000) $334 Avg Close — Range —
Q3 2021
Shares 20,491 Value ($000) $571 Avg Close — Range —
Q2 2021
Shares 20,491 Value ($000) $607 Avg Close — Range —
Q1 2021
Shares 20,491 Value ($000) $573 Avg Close — Range —
Q4 2020
Shares 20,491 Value ($000) $581 Avg Close — Range —